226950 Stock Chart & Stats
₩107000.00
-₩6,700.00(-5.89%)
―
--
Day’s Range― - ―
52-Week Range₩42,850.00 - ₩217,000.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)327.41K
Market Cap
₩2.39T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.20
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding21,062,850
10 Day Avg. Volume265,961
30 Day Avg. Volume327,412
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-2,273,127.75
Revenue Forecast (FY)₩11.75T
226950 FAQ
What was OliX Pharmaceuticals, Inc.’s price range in the past 12 months?
OliX Pharmaceuticals, Inc. lowest stock price was ₩42850.00 and its highest was ₩217000.00 in the past 12 months.
What is OliX Pharmaceuticals, Inc.’s market cap?
OliX Pharmaceuticals, Inc.’s market cap is ₩2.39T.
When is OliX Pharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were OliX Pharmaceuticals, Inc.’s earnings last quarter?
OliX Pharmaceuticals, Inc. released its earnings results on May 15, 2026. The company reported -₩439.871 earnings per share for the quarter, missing the consensus estimate of N/A by -₩439.871.
Is OliX Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts OliX Pharmaceuticals, Inc.’s price is currently Undervalued.
Does OliX Pharmaceuticals, Inc. pay dividends?
OliX Pharmaceuticals, Inc. does not currently pay dividends.
What is OliX Pharmaceuticals, Inc.’s EPS estimate?
OliX Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OliX Pharmaceuticals, Inc. have?
OliX Pharmaceuticals, Inc. has 21,062,850 shares outstanding.
What happened to OliX Pharmaceuticals, Inc.’s price movement after its last earnings report?
OliX Pharmaceuticals, Inc. reported an EPS of -₩439.871 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.925%.
Which hedge fund is a major shareholder of OliX Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in KR:226950
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
GC Biopharma Corp.
―
Hanall Biopharma Co., Ltd.
―
Celltrion Pharm Inc.
―
Mezzion Pharma Co., Ltd.
―
HK inno.N Corporation
―